Dr. Schlesinger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7501 Osler Drive
G-18
Towson, MD 21204Phone+1 410-427-5585Fax+1 410-427-5116- Is this information wrong?
Summary
- I am a board certified medical oncologist and hematologist. Most of my practice is breast oncology but I am comfortable seeing all solid tumors and enjoy benign hematology. I am medical director of the St. Joseph Cancer Center, a member of the University of Maryland Medical System in Baltimore, Maryland.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2000 - 2003
University of Virginia Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Pittsburgh School of MedicineClass of 1997
Certifications & Licensure
MD State Medical License 2019 - 2025
PA State Medical License 2001 - 2024
VA State Medical License 1997 - 2024
NC State Medical License 2003 - 2007- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Publications & Presentations
PubMed
- 8 citationsThe NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PML.Elizabeth A. Rush, Kimberly W. Schlesinger, Simon C. Watkins, Robert L. Redner> ;Leukemia Research. 2006 Aug 1
- 99 citationsPretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease.Margaret V. Ragni, Bijan Eghtesad, Kimberly W. Schlesinger, Igor Dvorchik, John J. Fung> ;Liver Transplantation. 2005 Nov 1
Press Mentions
Can Happy Hour Give You Cancer?October 25th, 2019
Professional Memberships
- Member
Hospital Affiliations
Riverside Regional Medical CenterNewport News, Virginia
Riverside Walter Reed HospitalGloucester, Virginia- Sentara Williamsburg Regional Medical CenterWilliamsburg, Virginia
Spotsylvania Regional Medical CenterFredericksburg, Virginia
VCU Health Tappahannock HospitalTappahannock, Virginia
University of Maryland St. Joseph Medical CenterTowson, Maryland
University of Maryland Medical CenterBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
